These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9502441)

  • 41. Chronic recurrent osteomyelitis: A diagnostic and therapeutic challenge.
    Rivas Felice J; González Herranz P; Mejía Casado A; Pérez Navarro R; Hernández Díaz R
    Rev Esp Cir Ortop Traumatol; 2017; 61(1):35-42. PubMed ID: 27514713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of bisphosphonates of adjuvant therapy in breast cancer].
    Gálvez-Muñoz E; Rodríguez-Lescure Á
    Med Clin (Barc); 2010 Jun; 135(2):70-4. PubMed ID: 20022069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
    Chogle AR; Mishra H; Chakravarty A
    J Assoc Physicians India; 2007 May; 55():380; author reply 380-1. PubMed ID: 17844703
    [No Abstract]   [Full Text] [Related]  

  • 44. Chronic nonbacterial osteomyelitis in children: a retrospective multicenter study.
    Kaiser D; Bolt I; Hofer M; Relly C; Berthet G; Bolz D; Saurenmann T
    Pediatr Rheumatol Online J; 2015 Jun; 13():25. PubMed ID: 26088861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful management of chronic multifocal Q fever Osteomyelitis with adjuvant interferon-gamma therapy.
    Neth OW; Falcon D; Peromingo E; Soledad Camacho M; Rodríguez-Gallego C; Obando I
    Pediatr Infect Dis J; 2011 Sep; 30(9):810-2. PubMed ID: 21372749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.
    Sedghizadeh PP; Sun S; Junka AF; Richard E; Sadrerafi K; Mahabady S; Bakhshalian N; Tjokro N; Bartoszewicz M; Oleksy M; Szymczyk P; Lundy MW; Neighbors JD; Russell RG; McKenna CE; Ebetino FH
    J Med Chem; 2017 Mar; 60(6):2326-2343. PubMed ID: 28121436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.
    Taddio A; Zennaro F; Pastore S; Cimaz R
    Paediatr Drugs; 2017 Jun; 19(3):165-172. PubMed ID: 28401420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug therapy for osteoporosis patients with low back pain].
    Yamazaki K
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():577-80. PubMed ID: 18161169
    [No Abstract]   [Full Text] [Related]  

  • 49. Vertebral collapse in an 8-year-old girl.
    Walls T; Bate J; Moshal K
    J Paediatr Child Health; 2006 Apr; 42(4):212-4. PubMed ID: 16630324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effects of TRK-530 on rat adjuvant arthritis.
    Tanahashi M; Funaba Y; Itoh M; Kawabe N; Nakadate-Matsushita T
    Pharmacology; 1998 May; 56(5):242-51. PubMed ID: 9597691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO).
    Hofmann SR; Kubasch AS; Range U; Laass MW; Morbach H; Girschick HJ; Hedrich CM
    Rheumatol Int; 2016 Jun; 36(6):769-79. PubMed ID: 27000045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bisphosphonates--targeting bone in the treatment of spondyloarthritis.
    Haibel H; Braun J; Maksymowych WP
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S162-6. PubMed ID: 12463470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis.
    Tanaka KS; Dietrich E; Ciblat S; Métayer C; Arhin FF; Sarmiento I; Moeck G; Parr TR; Far AR
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1355-9. PubMed ID: 20097069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anakinra in a Cohort of Children with Chronic Nonbacterial Osteomyelitis.
    Pardeo M; Pires Marafon D; Messia V; Garganese MC; De Benedetti F; Insalaco A
    J Rheumatol; 2017 Aug; 44(8):1231-1238. PubMed ID: 28620059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging and future therapies for the treatment of bone loss associated with chronic inflammation.
    Haynes DR
    Inflammopharmacology; 2006 Dec; 14(5-6):193-7. PubMed ID: 17093901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of ankylosing spondylitis.
    Scalapino KJ; Davis JC
    Clin Exp Med; 2003 Feb; 2(4):159-65. PubMed ID: 12624705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis.
    Otto S; Troeltzsch M; Burian E; Mahaini S; Probst F; Pautke C; Ehrenfeld M; Smolka W
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1837-42. PubMed ID: 26421465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liposomes--an invaluable tool in bisphosphonate research.
    Mönkkönen J
    Cell Mol Biol Lett; 2002; 7(2):241-2. PubMed ID: 12097933
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chronic, nonbacterial, multicentric osteomyelitis in the mandible].
    Danka E; Pintér GT; Keresztúri M; Szabó G
    Orv Hetil; 2018 Oct; 159(43):1761-1766. PubMed ID: 30346236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate.
    Hofmann C; Wurm M; Schwarz T; Neubauer H; Beer M; Girschick H; Morbach H
    Clin Exp Rheumatol; 2014; 32(4):604-9. PubMed ID: 25065777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.